SCHEMBL20061803

SCHEMBL20061803

c1ccc2c(c1)C1c3ccncc3C2c2nccnc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.33
FGFR1 P11362 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
HTT P42858 1/20 0.31
RAD52 P43351 1/20 0.31
GAA P10253 1/20 0.30
ADRA2A P08913 1/20 0.30
ADRA1D P25100 1/20 0.30
ADRA1A P35348 1/20 0.30
ADRA1B P35368 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20061790 0.88 PDPK1 (0.35) HSP90AA1MEN1KMT2AKDM4EPOLB
SCHEMBL20061785 0.85 L3MBTL1 (0.38) HSP90AA1L3MBTL1MEN1KMT2AMAOA
SCHEMBL20061792 0.85 KMT2A (0.39) HSP90AA1MEN1KMT2AKDM4EPOLB
SCHEMBL20061786 0.82 CYP2A6 (0.33) HSP90AA1L3MBTL1ADRA2AADRA1DADRA1A
SCHEMBL20061807 0.82 CYP2A6 (0.33) HSP90AA1L3MBTL1ADRA2AADRA1DADRA1A
SCHEMBL20061815 0.78 KDM4E (0.34) KDM4EHTTALDH1A1
SCHEMBL20061813 0.78 CYP2A6 (0.31)
SCHEMBL20061814 0.75 NOS3 (0.34) HSP90AA1MEN1KMT2AKDM4EPOLB
SCHEMBL20061801 0.74 CYP17A1 (0.38) L3MBTL1KDM4EPOLBHTTRAD52
SCHEMBL20061788 0.73 PDPK1 (0.38) MEN1KMT2AKDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180108848-A1 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108848-A1 Organic electroluminescent materials and devices OSBP, OSBP2, OCIAD2 HSP90AA1 4491/4885L3MBTL1 1467/4885FGFR1 3989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.